• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » John Fox

Articles by John Fox

Brown adipose tissue transplant ameliorates PCOS

March 2, 2016
By John Fox
HONG KONG — Researchers in China have demonstrated that endogenous brown adipose tissue (BAT) is closely related to the development of a polycystic ovarian syndrome (PCOS) phenotype in rats, suggesting that BAT activation might represent a promising therapeutic option for management of PCOS in humans.
Read More

Diabetes discovery may lead to stem cell-based therapies

Feb. 26, 2016
By John Fox

Diabetes discovery may lead to stem cell-based therapies

Feb. 24, 2016
By John Fox
HONG KONG – New results from researchers at the University of Kyoto in Japan suggest that pancreatic exocrine tissue, which is primarily involved in digestion, could also play an important role in the development of diabetes, a key finding that could lead to new treatments for the disease, including the potential for stem cell-based therapies.
Read More

Diabetes discovery may lead to stem cell-based therapies

Feb. 24, 2016
By John Fox
HONG KONG – New results from researchers at the University of Kyoto in Japan suggest that pancreatic exocrine tissue, which is primarily involved in digestion, could also play an important role in the development of diabetes, a key finding that could lead to new treatments for the disease, including the potential for stem cell-based therapies.
Read More

New drug target identified for dengue

Feb. 17, 2016
By John Fox
HONG KONG – A protein identified in the dengue virus by Dutch researchers could represent a promising new target for the development of an antiviral drug against dengue fever, a vaccine and effective treatment for which both remain elusive, report researchers from Radboud University Medical Center in Nijmegen, the Netherlands.
Read More

New drug target identified for dengue

Feb. 12, 2016
By John Fox
HONG KONG – A protein identified in the dengue virus by Dutch researchers could represent a promising new target for the development of an antiviral drug against dengue fever, a vaccine and effective treatment for which both remain elusive, report researchers from Radboud University Medical Center in Nijmegen, the Netherlands.
Read More

Axon regeneration promoted by neuronal activity enhancement

Feb. 8, 2016
By John Fox
HONG KONG – Neurobiologists at the Hong Kong University of Science and Technology (HKUST) have discovered a novel strategy to promote axon regeneration after central nervous system (CNS) injury, which could lead to the development of potentially clinically useful non-invasive methods to stimulate neuronal activity and eventually the possible repair of spinal injury.
Read More

Targeting receptor heterodimers may offer new antihypertensives

Jan. 27, 2016
By John Fox
HONG KONG – Japanese researchers have discovered that increased heterodimerization between angiotensin type 1 (AT1) receptors and purinergic P2Y6 receptors with age promotes hypertension induced by angiotensin II (ATII), and compounds that disrupt heterodimerization may be attractive new drug candidates to treat hypertension.
Read More

Targeting receptor heterodimers may offer new antihypertensives

Jan. 26, 2016
By John Fox
HONG KONG – Japanese researchers have discovered that increased heterodimerization between angiotensin type 1 (AT1) receptors and purinergic P2Y6 receptors with age promotes hypertension induced by angiotensin II (ATII), and compounds that disrupt heterodimerization may be attractive new drug candidates to treat hypertension.
Read More

Antifungal drug could prove answer to multidrug resistance

Jan. 20, 2016
By John Fox
HONG KONG — Chinese researchers have discovered that an antifungal drug can efficiently block bacterial virulence due to Staphylococcus aureus infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA) strains of the bacterium, in mouse models of infection, they reported in the Jan. 18, 2015, edition of Nature Chemical Biology.
Read More
Previous 1 2 … 48 49 50 51 52 53 54 55 56 … 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 23, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 23, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 27, 2025
  • Vertex divulges new Nav1.8 blockers for pain

    BioWorld Science
    Vertex Pharmaceuticals Inc. has synthesized sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers reported to be useful for the treatment of pain.
  • 3d rendering of bispecific antibodies

    Pfizer bets $6B+ on 3Sbio’s bispecific PD-1/VEGF antibody

    BioWorld
    Pfizer Inc. is paying $1.25 billion up front and up to $4.8 billion in milestone payments to gain global, ex-China rights to SSGJ-707, a PD-1/VEGF bispecific...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe